Clinical Trials

50 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Rectal Neoplasms

NCT00656448 2018-05-30

A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS

MyeloidOther hematologic neoplasm

51 enrolled 7 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00338286 2018-03-19

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

BreastClassical hematology

2,098 enrolled 12 charts

Anemia, Breast Neoplasms, Neoplasm Metastasis

NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

114 enrolled 10 charts

Anemia

NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Classical hematologyGynecologic

114 enrolled

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00058331 2016-07-18

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

Classical hematologyLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

365 enrolled

Anemia, Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

344 enrolled

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Phase 3 Unknown

80 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

NCT00003341 2013-07-03

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

275 enrolled

Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

NCT00148421 2013-05-15

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Anemia

NCT00017277 2012-09-24

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

47 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00036400 2011-06-10

Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery

Classical hematologyGastrointestinal

60 enrolled

Anemia, Rectal Neoplasms, Stomach Neoplasms

NCT00210587 2011-06-10

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

51 enrolled

Anemia, Neoplasms

NCT00210730 2011-06-10

The Duration Study

2 enrolled

Anemia, Neoplasms

NCT00341055 2011-06-10

A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.

69 enrolled

Anemia, Neoplasms

NCT00261677 2011-05-23

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

Classical hematologyLymphoidOther hematologic neoplasm

224 enrolled

Anemia, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00246597 2011-05-19

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

BreastClassical hematology

37 enrolled

Anemia, Breast Neoplasms, Red-Cell Aplasia, Pure

NCT00350090 2011-05-19

A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.

98 enrolled

Anemia, Neoplasms

NCT00270101 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Classical hematologyPlasma cell

156 enrolled

Anemia, Multiple Myeloma, Neoplasms

NCT00270127 2011-05-18

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

375 enrolled

Anemia, Neoplasms

NCT00270166 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy